Enterprise Ireland

Galway Biomedical specializes in the development and manufacturing of medical devices, focusing primarily on surgical implants. Their product portfolio spans various clinical fields, including vascular, dental, orthopaedic, urology, and general surgery, contributing to advancements in biomaterial-based medical device implants.

LaNua Medical is a medical technology company that develops innovative, image-guided devices for endovascular procedures. Their primary product is a medical device designed to block blood flow in specific segments of veins or arteries, aiding in the treatment of internal bleeding, vascular malformations, and both benign and malignant tumors. This technology enables healthcare professionals to enhance patient outcomes, reduce procedure times, and lower healthcare costs by minimizing hospital stays.

NUA Surgical is an award-winning company based in Galway, Ireland, developing and manufacturing surgical instruments for obstetrics and gynecology. Its patented disposable C-section retractor is designed to improve ergonomics and safety during caesarean deliveries, aiming to reduce complications and support safer care for mothers and infants.

Ovagen is a biotechnology company specializing in the commercial production of germ-free chicken eggs and birds. Primarily serving the pharmaceutical industry, Ovagen offers contract research services and expertise in specific poultry and rodent research technologies to Good Manufacturing Practice (GMP) standards.

SymPhysis Medical is focused on developing innovative medical technologies aimed at treating chronic diseases, with a particular emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, is a therapeutic device designed for the home management of malignant pleural effusions (MPE), a common complication in late-stage cancer patients. MPE can lead to severe symptoms such as shortness of breath and chest pain, affecting approximately 15% of cancer patients. The releaze device effectively drains excess fluid from the pleural space, utilizing an active component to improve removal efficiency. This technology not only alleviates debilitating symptoms but also makes indwelling pleural catheter treatments more accessible for patients, significantly contributing to their overall well-being.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Vertigenius operates a digital platform for vestibular rehabilitation, assisting clinicians in managing patients with dizziness and balance issues. The platform enables clinicians to design and prescribe customized exercises, which patients can access and track using a mobile application. Vertigenius also employs a head sensor for patient consultations.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

BeyondBMI is a health technology company focused on weight management, offering a comprehensive platform that supports individuals living with obesity. The company provides access to doctor-prescribed weight loss medications, nutritional therapy, and personalized accountability coaching. BeyondBMI aims to deliver non-judgmental medical expertise and the latest therapeutic options, enabling customers to achieve their weight loss goals effectively. By combining the skills of doctors, nutritionists, and health coaches, the company emphasizes support, motivation, and accountability, helping clients transform their lives and improve their overall health.

CergenX develops an AI-driven neonatal neurotechnology that enhances brain health monitoring in newborns. Its platform transforms electroencephalogram technology into a simple test, enabling early detection of brain injuries without requiring specialist training.

pHetalSafe is a medical technology company that specializes in the development of an innovative fetal monitoring system. This system measures fetal lactate and pH levels during labor, aiming to more accurately detect fetal distress and hypoxia, conditions that can lead to long-term brain damage in newborns. By providing health workers with valuable data, pHetalSafe's technology enables better-informed clinical decisions, ultimately promoting optimal patient outcomes.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

Developer of drug diffusion technology designed for long-term subcutaneous drug delivery in chronic disease management purposes. The company's product focuses on extending the functional lifespan and reliability of infusion components used in insulin pumps by addressing issues such as cannula occlusion and early failure, enabling patients with type one diabetes to maintain more consistent insulin therapy, reduce treatment interruptions, lower medical waste, and improve overall glycemic control.

Novus Diagnostics develops a point-of-care diagnostic system for infectious diseases, including a sample-to-answer sepsis platform that rapidly detects and classifies pathogens in whole blood. The device provides automated pathogen identification within minutes from a blood sample, allowing healthcare providers to diagnose sepsis-related infections and initiate timely, cost-effective treatment.

Signum Surgical is a medtech company developing bio-absorbable implant devices to treat colorectal diseases, with a focus on perianal fistulas. Founded in 2014 by Eoin Bambury and Moshe Zilversmit and based in Galway, Ireland, the company aims to prevent reinfection and accelerate healing after fistula surgery. Its devices securely close the fistula tract and dissolve within the body after treatment, enabling long-lasting healing.

xWave Technologies is a developer of innovative health platforms aimed at enhancing patient outcomes and streamlining health systems. The company's flagship product, xRefer, is recognized as Europe’s first Smart Radiology Referral Platform, created in collaboration with the European Society of Radiology. This platform utilizes artificial intelligence and machine learning technologies to optimize the referral, protocol, and scheduling processes for patients. By leveraging data resources, xWave Technologies seeks to provide predictive and personalized clinical decision support in medical diagnostics, thereby empowering healthcare professionals to make informed decisions and improve the overall efficiency of patient care.

Impedans specializes in developing intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their innovative products are designed to deliver high-resolution diagnostics and quality performance, with applications spanning fundamental research, process development, tool design, process control, and fault detection and classification. Serving diverse industries such as semiconductor, vacuum coating, medical devices, hard disks, and aerospace, Impedans leverages its extensive expertise in RF and plasma systems to provide independent diagnostics of process health. This enables clients to obtain accurate process measurements and effectively address complex processing challenges.

CergenX develops an AI-driven neonatal neurotechnology that enhances brain health monitoring in newborns. Its platform transforms electroencephalogram technology into a simple test, enabling early detection of brain injuries without requiring specialist training.

Gasgon Medical is a medical device company focused on enhancing intravenous (IV) infusion processes. It aims to improve patient safety and clinical efficiency by developing innovative devices that minimize risks such as Vascular Air Embolism. By supporting medical staff with better tools, Gasgon enables them to deliver superior patient care and outcomes.

SymPhysis Medical is focused on developing innovative medical technologies aimed at treating chronic diseases, with a particular emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, is a therapeutic device designed for the home management of malignant pleural effusions (MPE), a common complication in late-stage cancer patients. MPE can lead to severe symptoms such as shortness of breath and chest pain, affecting approximately 15% of cancer patients. The releaze device effectively drains excess fluid from the pleural space, utilizing an active component to improve removal efficiency. This technology not only alleviates debilitating symptoms but also makes indwelling pleural catheter treatments more accessible for patients, significantly contributing to their overall well-being.

Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

FeelTect is a medical device company based in Galway, Ireland, founded in 2019, that develops and markets pressure sensing devices for compression therapy of venous leg ulcers. Its device measures and monitors sub-bandage pressure, enabling live readings and recorded data to support safe, effective, individualized treatment during and outside clinical settings, with the aim of ensuring correct compression levels and reducing healthcare burden.

Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.

Tympany Medical develops a platform for minimally invasive ear surgeries. Its device enables surgeons to perform complex procedures using sterile endoscopy, reducing unnecessary mastoidectomies and enhancing surgical outcomes.

EquiTrace is a software solution for tracking horse identification and health. It facilitates contactless temperature monitoring using bio-thermo microchips, but remains functional with other microchip types. The platform stores medical records, enabling swift disease detection and daily health tracking.

Raydiant Oximetry is a medical device company developing a non-invasive fetal monitoring device that measures fetal oxygen levels to improve outcomes for mothers and babies during childbirth and to reduce unnecessary cesarean sections. Founded in 2015 and based in California, the company aims to provide low-cost, real-time monitoring of fetal oxygenation during labor, enabling clinicians to assess fetal well-being and minimize intervention.

HealthBeacon is a digital health company based in Dublin, Ireland, with additional offices in Canada and the United States. Founded in 2013, HealthBeacon specializes in developing connected devices to enhance treatment adherence for patients using self-injectable medications at home. Their flagship product, also named HealthBeacon, is designed to support patients by providing digital and home-based assistance to initiate therapy and improve overall compliance. The system includes features such as medication reminders, safe sharps disposal, educational tools, and data analytics driven by artificial intelligence. These components work together to monitor patient behavior, engage users, and ensure higher adherence to medication schedules.

InVera Medical specializes in developing innovative medical devices focused on treating chronic venous disease. Their flagship product, BioVena™, offers a less invasive, pain-free solution for varicose veins and venous ulcers, utilizing the body's natural biological response.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.

Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.

THEYA Healthcare designs and manufactures post-surgery garments and lingerie for women after breast cancer surgery, during radiotherapy, or after cosmetic procedures. Founded in 2015 by Ciara Donlon after identifying a gap in the post-surgery underwear market, the company developed a bamboo fabric range that is antibacterial, thermally regulating, and more absorbent and moisture-wicking than cotton to soothe skin and support healing during the four-week recovery. The products were tested in clinical trials across four Dublin teaching hospitals, with results showing improvements in body image and health status and reductions in irritation and pain compared with competing products. THEYA Healthcare has earned recognition including the Cartier Women’s Initiative Award and was a finalist for EY Entrepreneur of the Year in 2017.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

HealthBeacon is a digital health company based in Dublin, Ireland, with additional offices in Canada and the United States. Founded in 2013, HealthBeacon specializes in developing connected devices to enhance treatment adherence for patients using self-injectable medications at home. Their flagship product, also named HealthBeacon, is designed to support patients by providing digital and home-based assistance to initiate therapy and improve overall compliance. The system includes features such as medication reminders, safe sharps disposal, educational tools, and data analytics driven by artificial intelligence. These components work together to monitor patient behavior, engage users, and ensure higher adherence to medication schedules.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013, specializing in solutions for assessing physical function and preventing falls risk in older adults. The company has developed a patented platform that monitors and identifies mobility impairments by categorizing various mobility parameters, including walking, variability, symmetry, transfers, and turning. By comparing patients' mobility scores against population data based on age and gender, Kinesis Health Technologies provides a comprehensive method for evaluating falls risk and assessing gait, mobility, and frailty in a standardized manner. The team behind Kinesis Health Technologies possesses extensive experience in business, marketing, and technology, supported by 12 years of research conducted in Ireland.

Founded in 2017, Loci Orthopaedics specializes in developing innovative medical technologies for orthopedics. The company is renowned for its InDx implant, the only device that fully mimics natural thumb joint motions and offers a less invasive surgical treatment option.

Founded in 2015, Neurent Medical is a medical device company based in Galway, Ireland. It specializes in developing non-surgical treatments for chronic rhinitis using minimally invasive, hand-held radio-frequency devices.

ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.

Incereb is an Irish medical device company founded in May 2011 and headquartered in Dublin, specializing in the neonatal intensive care unit (NICU) market. The company focuses on the design and development of disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products specifically for term and preterm infants. These innovative products require minimal training for medical professionals, streamlining the setup process for EEG and CFM monitoring. Incereb's devices are compatible with all EEG and CFM recording equipment, enhancing their usability in diverse clinical settings. The company is committed to investing in research and development, product design, and extending its product range. By forming strategic alliances with leading Irish universities and hospitals, Incereb aims to leverage local scientific expertise to accelerate the commercialization of its novel devices, contributing to its rapid growth in the market.

The Hamstring Solo is an exercise aid for carrying out hamstring eccentric and concentric exercises.

Connexicon Medical Ltd., established in 2014 and headquartered in Dublin, Ireland, specializes in the manufacture of medical adhesives and sealants. Its primary products are tissue adhesives designed for both topical and internal applications, including medical adhesives used in topical wound care. These adhesives offer enhanced wound closure strength, a secure microbial barrier protection against common surgical site infection organisms, and durability for days, enabling healthcare professionals to provide effective wound closure solutions.

GlycoSeLect develops Recombinant Prokaryotic Lectins (RPLs) as tools for the analysis and purification of glycosylated biomolecules. Its platform uses recombinant prokaryotic lectin chemistry to recognize and bind specific glycan structures on glycoproteins and other glycosylated biomolecules, enabling affinity-based approaches for glycan analysis and purification in biopharma product workflows. Applications span glycobiology and glycoproteomics, biomarker discovery and diagnostics, and the biopharmaceutical, vaccine, and cosmetics sectors. The RPLs offer advantages such as production in Escherichia coli, high purity and consistent performance, enhanced glycan-binding properties, and scalable manufacture for large-scale use.

Coroflo Ltd. is a Dublin, Ireland-based company established in 2017 that specializes in developing innovative breastfeeding assistance technology. It has created the world's first breastfeeding monitor, which includes an application that tracks and analyzes the milk flow from mother to baby in real time. This system provides valuable insights into the amount of breast milk an infant consumes during feeding sessions, enhancing the breastfeeding experience for both mothers and their children. Through its technology, Coroflo aims to empower parents with data that supports infant nutrition and promotes breastfeeding.

Rockfield Medical Devices is a forward-thinking small to medium enterprise focused on human-centered design within the medical device sector. Founded by an industry expert, the company comprises a team of recognized professionals from medical device research and design. Rockfield is dedicated to becoming a global leader in the enteral feeding market, aiming to enhance user satisfaction through innovative, plug-and-play technologies that prioritize design, usability, and mobility. The company's platform significantly improves the mobility and quality of life for individuals relying on tube feeding, while also streamlining technical support and reducing maintenance costs for sales partners. By offering a user-friendly, lightweight, and discreet mobile feeding system, Rockfield Medical Devices seeks to transform service models in the enteral feeding community.

Allergy Lifestyle, established in 2013, is an online retailer specializing in products for individuals managing allergies and asthma. Founded by Anne Walsh, who drew from her personal experience caring for her daughter with multiple food allergies, the company provides a range of items such as Epipen cases, medication bags, medical support accessories, and allergy-friendly products. Through its platform, Allergy Lifestyle aims to empower and support individuals navigating their allergy journey by offering relevant information and essential products.

CMC Hygea Ltd. is a manufacturer of Class 1 medical devices focused on developing hygienic healthcare products that aim to prevent infectious diseases. The company's offerings include an innovative patient bathing system designed to inhibit the spread of bacteria responsible for Healthcare-Associated Infections (HAIs) and effective solutions for cleaning and treating leg ulcers. By providing these infection control products, CMC Hygea contributes significantly to enhancing safety and hygiene within the global healthcare system.

ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Qualio designs and develops cloud-based quality management software for life sciences companies. Its platform streamlines premarket activities, registration, regulatory compliance, document control, training, design controls, supplier QA, risk management, complaint handling, corrective actions, change control, internal audits, management reviews, and equipment management. Used by medical device manufacturers, pharma, biotech firms, and contract service providers worldwide.

PolyDev is a limited company set up to bring specialist innovation to the cosmetic contact lens market. It has a core competence in biomedical inks and printing, and has used this expertise to bring the TORIColors lens to market. PolyDev is the manufacturer of TORIColors brand of cosmetic contact lens. They are on sale in the US currently and will be released to other countries as regulatory compliance is achieved.

OrthoXel DAC is an emerging medical device startup company founded in 2014 to develop and commercialise orthopaedic trauma products. The first technology that OrthoXel will commercialise is a novel intramedullary nail for treatment of tibia and femoral fractures (Apex Nailing system ). The basic R&D and proof of principle was completed in Cork Institute of Technology’s MEDIC centre over a 5 year timeframe. That development program included iterative design-build-test activities such as bench testing, cadaver studies, and a GLP-controlled preclinical study. The output from the development program is patent-protected for tibial, femoral, and humeral use. OrthoXel will bring the Apex Tibial Nailing system through regulatory approval and clinical studies in early 2017, followed by the Apex Femoral Nailing system.

Signum Surgical is a medtech company developing bio-absorbable implant devices to treat colorectal diseases, with a focus on perianal fistulas. Founded in 2014 by Eoin Bambury and Moshe Zilversmit and based in Galway, Ireland, the company aims to prevent reinfection and accelerate healing after fistula surgery. Its devices securely close the fistula tract and dissolve within the body after treatment, enabling long-lasting healing.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013, specializing in solutions for assessing physical function and preventing falls risk in older adults. The company has developed a patented platform that monitors and identifies mobility impairments by categorizing various mobility parameters, including walking, variability, symmetry, transfers, and turning. By comparing patients' mobility scores against population data based on age and gender, Kinesis Health Technologies provides a comprehensive method for evaluating falls risk and assessing gait, mobility, and frailty in a standardized manner. The team behind Kinesis Health Technologies possesses extensive experience in business, marketing, and technology, supported by 12 years of research conducted in Ireland.

THEYA Healthcare designs and manufactures post-surgery garments and lingerie for women after breast cancer surgery, during radiotherapy, or after cosmetic procedures. Founded in 2015 by Ciara Donlon after identifying a gap in the post-surgery underwear market, the company developed a bamboo fabric range that is antibacterial, thermally regulating, and more absorbent and moisture-wicking than cotton to soothe skin and support healing during the four-week recovery. The products were tested in clinical trials across four Dublin teaching hospitals, with results showing improvements in body image and health status and reductions in irritation and pain compared with competing products. THEYA Healthcare has earned recognition including the Cartier Women’s Initiative Award and was a finalist for EY Entrepreneur of the Year in 2017.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.

Tapa Healthcare is an Irish Medical Technology start-up supported by Enterprise Ireland, armed with 18 years of clinical research, and the mission of providing proactive patient-centric care.

SiriusXT Limited is a company that specializes in the development and manufacturing of soft x-ray microscopes, specifically the SXT system. Founded in 2015 and headquartered in Dublin, Ireland, SiriusXT's innovative technology utilizes a vacuum-based laser-produced plasma light source to enable high-resolution imaging of biological samples. The SXT system is designed for researchers in disease research and drug discovery, providing a crucial tool for visualizing the 3D internal structures of cells in their native, fully hydrated state without the need for stains or contrast agents. This capability is essential for understanding disease pathways, protein-drug interactions, and bio-engineering processes. SiriusXT is recognized for offering the world's first high-throughput, benchtop soft x-ray tomography system, allowing users to produce detailed tomographs quickly and efficiently.

AventaMed Ltd. is a medical device company based in Cork, Ireland, specializing in the development of an innovative ENT device for the placement of tympanostomy tubes, commonly known as grommets. Founded as a spin-out from the MEDIC research centre at the Cork Institute of Technology, AventaMed has built its foundation on four years of intensive product development. The company's device aims to simplify surgical procedures, allowing for the insertion of ear tubes without the need for general anesthetic. This advancement is designed to enhance patient safety and improve care for individuals suffering from recurring ear infections and hearing loss, ultimately contributing to reduced healthcare costs.

DiaNia Technologies, based in Ireland, specializes in materials research and development services for medical device manufacturers. They focus on enhancing performance and functionality, particularly reducing friction in catheters through their proprietary extrusion technology. The company aims to improve patient safety, product reliability, and cost-effectiveness while maintaining high-quality standards and timely delivery. Their expertise lies in materials science and project management, targeting the early development phase of devices to maximize efficiency.

ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.

Qualio designs and develops cloud-based quality management software for life sciences companies. Its platform streamlines premarket activities, registration, regulatory compliance, document control, training, design controls, supplier QA, risk management, complaint handling, corrective actions, change control, internal audits, management reviews, and equipment management. Used by medical device manufacturers, pharma, biotech firms, and contract service providers worldwide.

Magnetar Medical Devices uses low-resistance electrode to develop advanced patch technologies for a needle-free delivery of drug.

Thalman Health is a developer of innovative wireless vital sign monitoring devices specifically designed for continuous tracking of body temperature. The company has created a novel core sensor technology that enables the real-time monitoring of patients' vital signs. Its wearable devices integrate seamlessly with a sensor-enabled platform, allowing healthcare providers to monitor patients around the clock. This technology not only tracks core body temperature but also alerts healthcare professionals to any deterioration in a patient’s condition, facilitating the early identification of fever and other health concerns. Through its advancements in thermometry, Thalman Health aims to enhance patient care and improve health outcomes.

PMD Solutions develops and markets medical devices for continuous respiratory monitoring. The flagship product RespiraSense is a discrete, motion-tolerant, body-worn sensor that continuously measures respiratory rate to monitor patients from administration to discharge, enabling early detection of deterioration and reducing the risk of respiratory failure. The system is commercially deployed in Europe and the United Kingdom and is FDA-cleared in the United States, targeting hospital and homecare settings.

Adama Innovations Ltd. is a company based in Dublin, Ireland, focused on developing nanotechnology solutions for advanced manufacturing. Established in 2010 as a spin-out from the CRANN nanotechnology institute at Trinity College Dublin, Adama Innovations specializes in creating high-resolution nanoscale probes fabricated from diamond. These probes are designed for use in atomic force microscopy, enabling precise imaging, measurement, and manipulation at the nanoscale. The company’s innovative technology allows for the creation of micro-patterns on ultra-hard materials, which can be applied in various industries, including medical device fabrication, labeling, and anti-counterfeiting. Additionally, Adama Innovations offers a range of products, including diamond sharp cones and flare-shaped probes, to enhance capabilities in metrology and precision engineering.

Embo Medical, located at the National University of Ireland, is focused on developing innovative medical devices for vascular embolization. The company is creating the Caterpillar, a groundbreaking one-shot embolization device designed to enhance the efficiency and safety of peripheral vascular embolization procedures. This device aims to significantly reduce procedural times, enabling physicians to perform embolizations in a more cost-effective manner. With approximately 180,000 such procedures conducted annually worldwide, Embo Medical is positioned to make a meaningful impact in the medical field by improving patient outcomes and streamlining medical practices.

Apica Cardiovascular is a pre-revenue medical device company specializing in a technology for accessing and closing the heart's apex and peripheral vascular system. This technology standardizes access and closure for large bore therapeutic devices without blood loss, enabling minimally invasive surgical or percutaneous procedures on the beating heart. It has applications in Transcatheter Heart Valves (TAVI), Abdominal Aortic Aneurysm (AAA) repair, and Left Ventricular Assist Device (LVAD) implantation. After successful animal and cadaver model testing, the technology is now advancing towards initial clinical trials.

PMD Solutions develops and markets medical devices for continuous respiratory monitoring. The flagship product RespiraSense is a discrete, motion-tolerant, body-worn sensor that continuously measures respiratory rate to monitor patients from administration to discharge, enabling early detection of deterioration and reducing the risk of respiratory failure. The system is commercially deployed in Europe and the United Kingdom and is FDA-cleared in the United States, targeting hospital and homecare settings.

Founded in 2010, SurgaColl Technologies Ltd. is a medical devices company based in Cork, Ireland. It specializes in developing novel tissue regeneration products for the surgical treatment of bone, cartilage, and other human tissue diseases. The company's products, HydroxyColl and ChondroColl, are bioactive scaffolds designed to support the body's natural healing processes.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

neoSurgical Limited is an Irish company focused on developing innovative medical devices specifically for laparoscopic abdominal surgery. Established in 2007 and located in Campus, Ireland, neoSurgical has created the neoClose technology, which is designed to assist surgeons by enhancing the safety and efficiency of closing laparoscopic incision sites. This product aims to reduce the risk of herniation complications associated with laparoscopic procedures, thereby improving patient outcomes. Through its commitment to technical innovation, neoSurgical seeks to address challenges within the surgical devices industry.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's core product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system. Neuromod's mission is to empower patients worldwide, including the 10% of adults affected by chronic tinnitus, by delivering targeted, non-invasive therapies that seamlessly integrate into daily life.

Radisens Diagnostics develops digital diagnostic devices for point-of-care testing. Their platform integrates immunochemistry, clinical chemistry, and haematology assays onto multiplexed test panels using just a drop of blood, providing instant results. Initially focusing on chronic disease panels such as diabetes and heart disease, the company aims to expand into cell counting, cardiac, and oncology targets.

NOvate Medical Technologies is a medical device development company based in New Orleans, dedicated to creating high-quality, low-cost, and sustainable medical products that address pressing global health challenges. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from potential infections. This innovative device aims to significantly reduce maternal and neonatal mortality rates, particularly in developing countries, by enhancing the safety of childbirth and allowing healthcare professionals to manage clots effectively. Through its focus on affordability and sustainability, NOvate Medical Technologies strives to improve healthcare outcomes in underserved communities.

SensL Technologies, Ltd. specializes in the manufacture of silicon photomultipliers, SPAD arrays, and measurement instruments. Founded in 2004 and headquartered in Cork, Ireland, with an additional facility in Somerville, Massachusetts, the company produces a range of products including high-resolution timing modules and photon counting systems. SensL's silicon photomultipliers are utilized across various sectors such as analytical instruments, homeland security, nuclear medicine, medical imaging, and environmental monitoring. The company is distinguished by its 'Micro' series of SiPM sensors, known for their low noise, high breakdown voltage uniformity, and low bias voltage requirements. SensL's products are marketed through a network of sales representatives across multiple countries including the United States, Canada, and several European nations. Since May 2018, SensL has operated as a subsidiary of ON Semiconductor Corporation, enhancing its capabilities in low light detection solutions for applications in medical imaging and autonomous driving technologies.

ChipSensors Ltd is a fabless semiconductor company established in 2007, specializing in the development and production of innovative sensors utilizing deep submicron CMOS technology for measuring temperature, humidity, and gases. The company is guided by a team of experienced professionals with a strong background in analog and mixed-signal semiconductor design and manufacturing. In addition to its core sensor products, ChipSensors offers consultancy, training, and design services that encompass custom sensor analysis, sensor ASIC design, mixed-signal integrated circuit design, and wireless hardware/software reference designs. This diverse expertise positions ChipSensors as a key player in the semiconductor industry, focusing on cutting-edge sensor solutions.

BiancaMed is a health technology company focused on transforming personal health management through innovative monitoring solutions. Recognizing the rising healthcare costs and the increasing prevalence of chronic conditions, the company aims to facilitate health management in everyday environments, particularly within the home. BiancaMed has developed non-contact devices for diagnosing and managing sleep-disordered breathing and other respiratory issues. Its flagship products include Sleepminder, which monitors sleep quality, respiration, sleep efficiency, and apnea events in adults, and BiancaBaby, a motion and respiration sensor designed for infants. At the core of these products is a highly sensitive motion sensor that wirelessly detects heart rate and respiration, providing users with the convenience of health monitoring without physical contact.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

NOvate Medical Technologies is a medical device development company based in New Orleans, dedicated to creating high-quality, low-cost, and sustainable medical products that address pressing global health challenges. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from potential infections. This innovative device aims to significantly reduce maternal and neonatal mortality rates, particularly in developing countries, by enhancing the safety of childbirth and allowing healthcare professionals to manage clots effectively. Through its focus on affordability and sustainability, NOvate Medical Technologies strives to improve healthcare outcomes in underserved communities.

ChipSensors Ltd is a fabless semiconductor company established in 2007, specializing in the development and production of innovative sensors utilizing deep submicron CMOS technology for measuring temperature, humidity, and gases. The company is guided by a team of experienced professionals with a strong background in analog and mixed-signal semiconductor design and manufacturing. In addition to its core sensor products, ChipSensors offers consultancy, training, and design services that encompass custom sensor analysis, sensor ASIC design, mixed-signal integrated circuit design, and wireless hardware/software reference designs. This diverse expertise positions ChipSensors as a key player in the semiconductor industry, focusing on cutting-edge sensor solutions.

Eblana Photonics Ltd. is a manufacturer of laser diode products, specializing in applications for the space, medical, sensor, and fiber-optic communications industries. Founded in 2001 by Dr. James O’Gorman and Prof. John Hegarty, the company emerged from advanced research initiatives in photonics at leading Irish universities, particularly Trinity College Dublin. Eblana Photonics focuses on developing scalable laser manufacturing technologies that reduce costs while delivering high-performance, single-wavelength lasers suitable for various mass market applications, including broadband, access, and enterprise markets. In addition to its product offerings, the company provides contract research and development services, leveraging its expertise to meet the specific needs of its clients. Headquartered in Dun Laoghaire, Ireland, Eblana has expanded its presence internationally with offices in France, Germany, the United States, Japan, China, and Taiwan.

Cellix Ltd., established in 2004, specializes in the development, manufacturing, and distribution of microfluidic pumping solutions and associated products. Based in Dublin, Ireland, with an additional office in New York, the company serves biology laboratories across academia, government, and the pharmaceutical and biotechnology industries worldwide. Cellix's portfolio includes micro fluidic pumps, biochips mimicking human capillaries, and software for cell analysis. These solutions enable researchers to perform in-vitro assays under physiological conditions, mimicking in-vivo conditions of the blood vessel, and study drug effects on cell activity for various applications such as cardiovascular, oncology, and infectious diseases. The company's products are sold through distributors in Europe and Asia.